Cargando…

Targeting nucleic acid phase transitions as a mechanism of action for antimicrobial peptides

Antimicrobial peptides (AMPs), which combat bacterial infections by disrupting the bacterial cell membrane or interacting with intracellular targets, are naturally produced by a number of different organisms, and are increasingly also explored as therapeutics. However, the mechanisms by which AMPs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sneideris, Tomas, Erkamp, Nadia A., Ausserwöger, Hannes, Saar, Kadi L., Welsh, Timothy J., Qian, Daoyuan, Katsuya-Gaviria, Kai, Johncock, Margaret L. L. Y., Krainer, Georg, Borodavka, Alexander, Knowles, Tuomas P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630377/
https://www.ncbi.nlm.nih.gov/pubmed/37935659
http://dx.doi.org/10.1038/s41467-023-42374-4
Descripción
Sumario:Antimicrobial peptides (AMPs), which combat bacterial infections by disrupting the bacterial cell membrane or interacting with intracellular targets, are naturally produced by a number of different organisms, and are increasingly also explored as therapeutics. However, the mechanisms by which AMPs act on intracellular targets are not well understood. Using machine learning-based sequence analysis, we identified a significant number of AMPs that have a strong tendency to form liquid-like condensates in the presence of nucleic acids through phase separation. We demonstrate that this phase separation propensity is linked to the effectiveness of the AMPs in inhibiting transcription and translation in vitro, as well as their ability to compact nucleic acids and form clusters with bacterial nucleic acids in bacterial cells. These results suggest that the AMP-driven compaction of nucleic acids and modulation of their phase transitions constitute a previously unrecognised mechanism by which AMPs exert their antibacterial effects. The development of antimicrobials that target nucleic acid phase transitions may become an attractive route to finding effective and long-lasting antibiotics.